Merck Sells Manufacturing Unit

| + More Articles
  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

drugs ecs

Africa’s largest drugmaker, Aspen Pharmacare Holdings is going to purchase Merck & Co.’s (NYSE:MRKpharmaceutical manufacturing unit. They also took the option to buy a products unit. The entire deal is worth about $1 billion.

According to Aspen chief executive officer Stephen Saad, “The active pharmaceutical ingredients are hard to source or replicate, and this allows us strong pipelines.” This is a chance for the company to extend its reach in emerging markets, such as Asia and Latin America.

The products business that Aspen is purchasing has 11 branded finished dosage formulas. Aspen stated that these products are for oral contraception, hormone replacement, and other therapeutic treatments.

More Articles About:

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business